index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Multi exon skipping Cell Biology Dynamin 2 Metabolism Calcium Channels Autophagy Modificateurs de gènes Exon skipping Knockout Génomique Dystrophie Musculaire de Becker BMD Long QT Myogenesis Dystrophine NAD+ LKB1 Animal/physiopathology Muscular Atrophy L-Type Dystrophin Mdx mouse Energy Metabolism/drug effects Morphogenesis CD38 Clinical trials Dystrophy Allele‐specific silencing therapy Animals MES Male Cell homeostasis Multi resolution modeling Long noncoding RNA Dystrophie musculaire de Becker Drp1 Becker muscular dystrophy BMD BMD Molecular Sequence Data Skeletal muscle Muscular Dystrophy Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Mice Cell Line Dystrophin-EGFP Dystrophie Musculaire de Duchenne DMD Muscles/physiopathology Cachexia Becker BMD muscular dystrophy DMO Muscle Muscle development Cells Liver Genomic CaVβs Invivo CTNNB1 Inbred mdx Muscle Biology Gene expression Becker muscular dystrophy CaV subunits Hepatocellular carcinoma Duchenne muscular dystrophy DMD Base Sequence Diseases Duchenne muscular dystrophy Gene modifiers MiARN Inbred C57BL Activin Receptors Ex-vivo Multiresolution modeling DHPR α1S Homeostasis LncRNA Hear Human Umbilical Vein Endothelial Cells Inhibitors Humans Delivery Mitochondrial fission LncARN Gene Expression Regulation/drug effects Muscle Strength Cardiomyopathy Cardiomyopathie Cultured Epigenetics Antisense oligonucleotides Myotendinous junction Calcium DMD Duchenne DMD dystrophy Molecular docking Dystrophin central domain NNOS Centronuclear myopathy Immunoglobulin Fc Fragments/pharmacology Muscular dystrophy